U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H26F2N2O2S
Molecular Weight 420.516
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NOP-1A

SMILES

CNC(=O)[C@H](CN1CCC2(CC1)OCCC3=C2SC(F)=C3)CC4=CC=CC=C4F

InChI

InChIKey=MZBCQWLYUQJXKA-KRWDZBQOSA-N
InChI=1S/C22H26F2N2O2S/c1-25-21(27)17(12-15-4-2-3-5-18(15)23)14-26-9-7-22(8-10-26)20-16(6-11-28-22)13-19(24)29-20/h2-5,13,17H,6-12,14H2,1H3,(H,25,27)/t17-/m0/s1

HIDE SMILES / InChI

Molecular Formula C22H26F2N2O2S
Molecular Weight 420.516
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

11C-NOP-1A is a new radioligand for thenociceptin/orphanin FQ peptide (NOP) receptor, with high affinity (Ki, 0.15 nM) and appropriate lipophilicity (measured logD, 3.4) for PET brain imaging. 11C-NOP-1A is the the first successful radioligand to image NOP receptors in rat and monkey brain. 11C-NOP-1A is a selective antagonist at the NOP receptor and has high affinity and appropriate lipophilicity for blood–brain barrier permeability. 11C-NOP-1A imaging in rhesus monkeys showed high brain uptake and a large receptor-specific signal and could be quantified with the gold standard method of compartmental modeling. In humans 1C-NOP-1A reliably quantified NOP receptors in human brain both in large brain regions and at a voxelwise level using parametric imaging. The radiation absorbed dose in humans was similar to that observed with other 11C-labeled ligands and would allow multiple scans of a single subject. Thus, 11C-NOP-1A is a promising radioligand for reliably quantifying NOP receptors in human brain.

Approval Year

PubMed

PubMed

TitleDatePubMed
Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors.
2011 Oct
Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
2012 Mar
Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
2014 Feb 15
Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [(11)C]NOP-1A.
2019 Jun 1

Sample Use Guides

After intravenous injection of 11C-NOP-1A, 7 healthy subjects underwent brain PET for 2 h and serial sampling of radial arterial blood to measure parent radioligand concentrations. The radioligand was obtained with high radiochemical purity (>99%) and aspecific activity of 213 ± 100 GBq/umol at the time of injection. The injected mass dose of 11C-NOP-1A was 53 ± 36 pmol/kg. The effective dose of 11C-NOP-1A (4.3 uSv/MBq) estimated from whole-body scans inhumans was similar to previous estimates (5 uSv/MBq) from monkey studies and tothose of 34 other 11C-radioligands used for brain imaging, which ranged from 3 to 16 uSv/MBq.
Route of Administration: Intravenous
11C-NOP-1A is a new radioligand for the nociceptin/orphanin FQ peptide (NOP) receptor, with high affinity (Ki, 0.15 nM) and appropriate lipophilicity (measured logD, 3.4) for PET brain imaging.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:06:29 GMT 2023
Edited
by admin
on Sat Dec 16 08:06:29 GMT 2023
Record UNII
DQY244459T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NOP-1A
Common Name English
SPIRO(PIPERIDINE-4,7'-(7H)THIENO(2,3-C)PYRAN)-1-PROPANAMIDE, 2'-FLUORO-.ALPHA.-((2-FLUOROPHENYL)METHYL)-4',5'-DIHYDRO-N-METHYL-, (.ALPHA.S)-
Systematic Name English
Code System Code Type Description
PUBCHEM
52951810
Created by admin on Sat Dec 16 08:06:29 GMT 2023 , Edited by admin on Sat Dec 16 08:06:29 GMT 2023
PRIMARY
DRUG BANK
DB15208
Created by admin on Sat Dec 16 08:06:29 GMT 2023 , Edited by admin on Sat Dec 16 08:06:29 GMT 2023
PRIMARY
FDA UNII
DQY244459T
Created by admin on Sat Dec 16 08:06:29 GMT 2023 , Edited by admin on Sat Dec 16 08:06:29 GMT 2023
PRIMARY
CAS
1283095-70-4
Created by admin on Sat Dec 16 08:06:29 GMT 2023 , Edited by admin on Sat Dec 16 08:06:29 GMT 2023
PRIMARY